Hiroyuki Kitayama

Amelioration of Cisplatin-Induced Acute Renal Injury by Renal Progenitor-Like Cells Derived from the Adult Rat Kidney

T. Sugaya, H. Sugiyama, Y. Maeshima, 2008, Cell transplantation.

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

H. Sugiyama, Y. Maeshima, H. Makino, 2004, Diabetes.

2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice

H. Sugiyama, Y. Maeshima, H. Makino, 2006, Diabetes.

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

K. Eguchi, H. Sugiyama, Y. Maeshima, 2005, Diabetes.

Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.

H. Kawachi, H. Sugiyama, Y. Maeshima, 2005, Kidney international.

Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.

H. Sugiyama, Y. Maeshima, H. Makino, 2006, American journal of hypertension.

Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.

H. Sugiyama, Y. Maeshima, H. Makino, 2007, Kidney International.